Touyun Biotech
Touyun Biotech, officially known as Touyun Biotech Holdings Limited, is a prominent player in the biotechnology industry, headquartered in Hong Kong. Founded in 2001, the company has established itself as a leader in the development and production of innovative biopharmaceuticals and health supplements, primarily focusing on traditional Chinese medicine and modern therapeutic solutions. With a strong operational presence across Asia, Touyun Biotech is renowned for its unique product offerings, which combine advanced biotechnological methods with traditional practices. The company’s commitment to quality and efficacy has garnered significant recognition, positioning it as a trusted name in the market. Notable achievements include successful collaborations and a robust portfolio of patented products, underscoring its dedication to advancing healthcare solutions.
DitchCarbon Score
How does Touyun Biotech's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Touyun Biotech's score of 25 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Touyun Biotech's reported carbon emissions
In 2023, Touyun Biotech reported total carbon emissions of approximately 7,546,700 kg CO2e, comprising 18,170 kg CO2e from Scope 1 and about 7,528,530 kg CO2e from Scope 2 emissions. This marked a significant reduction from previous years, with total emissions decreasing from about 31,7480 kg CO2e in 2021 and 50,1300 kg CO2e in 2020. The company has demonstrated a commitment to reducing its carbon footprint, although specific reduction targets or initiatives have not been disclosed. The absence of Scope 3 emissions in their reports indicates a focused approach on direct and indirect emissions from their operations. Overall, Touyun Biotech's emissions data reflects a trend towards lower emissions, aligning with broader industry efforts to address climate change and enhance sustainability practices.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 70,600 | 00,000 | 00,000 | 00,000 | 00,000 |
| Scope 2 | 654,300 | 000,000 | 000,000 | 00,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Touyun Biotech is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
